Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children

被引:8
|
作者
Laub, Otto [1 ]
Leipold, Georg [2 ]
Toncheva, Antoaneta A. [3 ]
Peterhoff, David [4 ,5 ]
Einhauser, Sebastian [4 ]
Neckermann, Patrick [4 ]
Borchers, Natascha [3 ]
Santos-Valente, Elisangela [3 ]
Kheiroddin, Parastoo [3 ]
Buntrock-Doepke, Heike [3 ,6 ]
Laub, Sarah [1 ]
Schoeberl, Patricia [3 ,6 ]
Schweiger-Kabesch, Andrea [3 ]
Ewald, Dominik [7 ]
Horn, Michael [8 ]
Niggel, Jakob [9 ]
Ambrosch, Andreas [10 ]
Ueberla, Klaus [11 ,12 ]
Gerling, Stephan [3 ]
Brandstetter, Susanne [3 ,6 ]
Wagner, Ralf [4 ,5 ]
Kabesch, Michael [3 ,6 ]
机构
[1] Pediat Off Laub, Rosenheim, Germany
[2] Pediat Off Dr Leipold, Regensburg, Germany
[3] Univ Regensburg, Hosp St Hedwig Order St John, Univ Childrens Hosp Regensburg KUNO, Regensburg, Germany
[4] Univ Regensburg, Inst Med Microbiol & Hyg, Mol Microbiol Virol, Regensburg, Germany
[5] Univ Hosp, Inst Clin Microbiol & Hyg, Regensburg, Germany
[6] Hosp St Hedwig Order St John, Res & Dev Campus Regensburg WECARE, Regensburg, Germany
[7] Pediat Off Dr Heuschmann & Dr Ewald, Regenstauf, Germany
[8] Pediat Off Dr Horn, Schonau, Germany
[9] Maganamed Ltd, Regensburg, Germany
[10] Hosp Order St John, Inst Lab Med Microbiol & Hyg, Regensburg, Germany
[11] FAU Erlangen Nuremberg, Inst Clin & Mol Virol, Erlangen, Germany
[12] Univ Klinikum Erlangen, Erlangen, Germany
来源
FRONTIERS IN PEDIATRICS | 2021年 / 9卷
关键词
antibody; neutralizing; COVID-19; SARS-CoV-2; children;
D O I
10.3389/fped.2021.678937
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children. Methods: In a cross-sectional design, children aged 1-17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined. Results: We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed. Conclusions: Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight
    Goldblatt, D.
    Johnson, M.
    Falup-Pecurariu, O.
    Ivaskeviciene, I.
    Spoulou, V
    Tamm, E.
    Wagner, M.
    Zar, H. J.
    Bleotu, L.
    Ivaskevicius, R.
    Papadatou, I
    Jogi, P.
    Lischka, J.
    Franckling-Smith, Z.
    Isarova, D.
    Grandjean, L.
    Zavadska, D.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 60 - 66
  • [42] Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study
    Seck, Sidy Mohamed
    Mbow, Moustapha
    Kane, Yaya
    Cisse, Mouhamadou Moustapha
    Faye, Gnagna
    Kama, Adama
    Sarr, Moussa
    Nitcheu, Pamela
    Dahaba, Mohamed
    Diallo, Ibrahima Mbemba
    Diawara, Mame Selly
    Latou, Lotingo Nehemie Motoula
    Dia, Yacine
    Mboup, Souleymane
    BMC NEPHROLOGY, 2021, 22 (01)
  • [43] Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies
    Schulz, Sebastian R.
    Hoffmann, Markus
    Roth, Edith
    Pracht, Katharina
    Burnett, Deborah L.
    Mazigi, Ohan
    Schuh, Wolfgang
    Manger, Bernhard
    Mielenz, Dirk
    Goodnow, Christopher C.
    Christ, Daniel
    Poehlmann, Stefan
    Jaeck, Hans-Martin
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (06) : 970 - 977
  • [44] Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD
    Errico, John M.
    Zhao, Haiyan
    Chen, Rita E.
    Liu, Zhuoming
    Case, James Brett
    Ma, Meisheng
    Schmitz, Aaron J.
    Rau, Michael J.
    Fitzpatrick, James A. J.
    Shi, Pei-Yong
    Diamond, Michael S.
    Whelan, Sean P. J.
    Ellebedy, Ali H.
    Fremont, Daved H.
    CELL REPORTS, 2021, 37 (04):
  • [45] Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine induced antibodies
    Wahid, M.
    Jawed, A.
    Mandal, R. K.
    Dailah, H. G.
    Janahi, E. M.
    Dhama, K.
    Somvanshi, P.
    Haque, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5857 - 5864
  • [46] Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
    Mishra, Nitesh
    Kumar, Sanjeev
    Singh, Swarandeep
    Bansal, Tanu
    Jain, Nishkarsh
    Saluja, Sumedha
    Kumar, Rajesh
    Bhattacharyya, Sankar
    Palanichamy, Jayanth Kumar
    Mir, Riyaz Ahmad
    Sinha, Subrata
    Luthra, Kalpana
    PLOS PATHOGENS, 2021, 17 (09)
  • [47] Testing for SARS-CoV-2 antibodies
    Watson, Jessica
    Richter, Alex
    Deeks, Jonathan
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [48] SnapShot: SARS-CoV-2 antibodies
    Montefiori, David C.
    Acharya, Priyamvada
    CELL HOST & MICROBE, 2021, 29 (07) : 1162 - +
  • [49] Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies
    Nan, Xuanyu
    Li, Yujie
    Zhang, Rui
    Wang, Ruoke
    Lv, Niannian
    Li, Jiayi
    Chen, Yuanfang
    Zhou, Bini
    Wang, Yangjunqi
    Wang, Ziyi
    Zhu, Jiayi
    Chen, Jing
    Li, Jinqian
    Chen, Wenlong
    Zhang, Qi
    Shi, Xuanling
    Zhao, Changwen
    Chen, Chunying
    Liu, Zhihua
    Zhao, Yuliang
    Liu, Dongsheng
    Wang, Xinquan
    Yan, Li-Tang
    Li, Taisheng
    Zhang, Linqi
    Yang, Yuhe R.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [50] The SARS-CoV-2 pandemic causes a dysfunctional dietary behavior: A German cross-sectional study
    Dinse, Hannah
    Schweda, Adam
    Baeuerle, Alexander
    Musche, Venja
    Fink, Madeleine
    Geiger, Sheila
    Skoda, Eva-Maria
    Teufel, Martin
    NUTRITION AND HEALTH, 2023,